Featured Research

from universities, journals, and other organizations

Early Oral Contraceptive Formulations Linked To Breast Cancer Risk

Date:
October 11, 2000
Source:
Mayo Clinic
Summary:
Mayo Clinic scientists have found that women with a strong family history of breast cancer who had ever taken oral contraceptives, particularly those introduced prior to 1975, may have a heightened risk of breast cancer.

ROCHESTER, Minn. -- Mayo Clinic scientists have found that women with a strong family history of breast cancer who had ever taken oral contraceptives, particularly those introduced prior to 1975, may have a heightened risk of breast cancer.

Related Articles


"If there is a risk associated with current formulations, we probably don't have the data to detect it," says Thomas Sellers, Ph.D., Mayo Clinic Cancer Center epidemiologist and senior investigator of this study. "What our data suggest is that it is early formulations with high doses of estrogen and progestins that pose a risk, not later ones. More importantly, these results don't apply for women at average risk for breast cancer, who should not interpret the study as reason to change their contraceptive practices."

The study, to be published in the Oct. 11, 2000, issue of Journal of the American Medical Association, found that the risk of breast cancer is 3.3 times greater for breast cancer patients' sisters and daughters who had ever used oral contraceptives compared to those with similar risk who had never used oral contraceptives. This did not apply to nieces, granddaughters or women who married into the family, who only had a 1.2-fold greater risk of breast cancer with pill usage. In families in which five or more blood relatives had been diagnosed with breast or ovarian cancer, the risk was even greater. In those families, sisters and daughters of the breast cancer patients were 11.4 times more likely to develop breast cancer if they had ever taken oral contraceptives.

The elevated risk for first-degree relatives (sisters, daughters) of breast cancer patients was particularly evident for women who had used oral contraceptives introduced prior to 1975, when the formulations were more likely to contain higher doses of estrogen and progestins. The study could not make statistically significant conclusions about sisters and daughters of breast cancer patients who had used more recent formulations of oral contraceptives containing lower doses of estrogen and progestins, due to the small number of women in the study who had taken them.

This is the first family, or multigenerational, study of the association between oral contraceptive use and the development of breast cancer in women with a family history of the disease. It included 426 families of women diagnosed with breast cancer between 1944 and 1952 at the Tumor Clinic of the University of Minnesota Hospital. Participants included 394 sisters and daughters of the breast cancer patients, 3,002 granddaughters and nieces, and 2,754 women who married into the families. Follow-up data were collected via phone interviews with these participants between 1991 and 1996.

"We knew that oral contraceptive use is weakly associated with breast cancer risk in the general population, but the association among women with a familial predisposition to the disease was less clear," says Dr. Sellers. "This new study gives us more information for that population."

Oral contraceptive use by women with a family history of breast cancer is an issue due to the ongoing controversy regarding its risks and benefits.

"This study provides information that must be considered in light of the recommendations that have been made for women at high genetic risk for breast or ovarian cancer to use oral contraceptives to reduce the risk of ovarian cancer," says Dr. Sellers. "Although there is a good body of scientific evidence that use of oral contraceptives does lower risk of ovarian cancer, we need to be sure that this doesn't come at the expense of an increased risk for breast cancer."

The study's authors do not recommend additional screening for women who have taken earlier formulations of oral contraceptives and also have first-degree relatives with breast cancer, but they encourage these women to be sure to follow the recommended screening guidelines.

"Prevention of breast cancer is our goal," says Dr. Sellers. "When that isn't possible, then early detection is essential. Women at high familial risk who've been exposed to oral contraceptives with high doses of estrogens and progestins should be particularly vigilant regarding mammography."


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Early Oral Contraceptive Formulations Linked To Breast Cancer Risk." ScienceDaily. ScienceDaily, 11 October 2000. <www.sciencedaily.com/releases/2000/10/001011071850.htm>.
Mayo Clinic. (2000, October 11). Early Oral Contraceptive Formulations Linked To Breast Cancer Risk. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2000/10/001011071850.htm
Mayo Clinic. "Early Oral Contraceptive Formulations Linked To Breast Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/2000/10/001011071850.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins